The global Transplant
Diagnostics market is foreseen to grow at 6.9%, from USD 4.6 Billion in 2021 to
USD 7.8 Billion in 2029. The demand for transplant diagnostic products is
expected to grow mainly due to factors such as the increasing public-private
funding for target research activities, the growing burden of infectious
diseases, the increasing number of transplant procedures, and technological
advancements in the field of transplant diagnostics.
In the case of
heart transplants, there is significant attention given to diagnostics
associated with pulmonary function and overall health. In the past decade, diagnostics have improved significantly with companies committed to developing
better HLA typing technologies, antibody monitoring, instrument, and software.
This is gradually being used for diagnostics during transplantation across
different organs of the body.
Along with
technological advancements, many transplant procedures are being performed by
the multispeciality hospitals in the developed markets, as well as growing
funding opportunities provided by the government and private collaborations.
The diagnosis in transplants is done at the donor's and patient's end, to
analyze the infection level inside an organ. However, some of the limitations
include the high cost of transplants, irregular insurance, reimbursement
policies, and social and ethical issues related to organ transplants.
COVID-19 Impact on Global Transplant
Diagnostics Market
The Transplant
Diagnostics is the supply line for organ transplantation, helping treat
patients. The continuous spread of COVID-19 has caused a massive decrease in
organ donation, thus negatively impacting the aspects of Transplant Diagnostics
in recent years. However, government and private entities have various
strategies to deliver proper care to patients during organ transplantation.
Market Segmentation
For the purpose
of this report, the global Transplant Diagnostics market is segmented on the
basis of product type, application type, end user and region:
Product and Services Outlook (Revenue, USD
million; 2018-2029)
|
Instruments
|
Reagents & Consumables
|
Software & Services
|
|
|
|
Technology Outlook (Revenue, USD million;
2018-2029)
|
Molecular Assay Technologies
|
PCR-Based Molecular Assays
|
Real-time PCR
|
|
|
Sequence-specific Oligonucleotide-PCR
|
|
|
Sequence-specific Primer-PCR
|
|
|
Other PCR-based Molecular Assays
|
|
Sequencing-based Molecular Assays
|
Next-generation Sequencing
|
|
|
Sanger Sequencing
|
|
|
Other Sequencing-based Molecular Assays
|
Non-molecular Assay Technologies
|
|
|
|
|
|
Transplant Type Outlook (Revenue, USD
million; 2018-2029)
|
Bone marrow Transplantation
|
|
|
Soft Tissue Transplantation
|
|
|
Solid Organ Transplantation
|
Kidney Transplantation
|
|
|
Heart Transplantation
|
|
|
Liver Transplantation
|
|
|
Lung Transplantation
|
|
|
Pancreas Transplantation
|
|
|
Other Organ Transplantations
|
|
Stem Cell Transplantation
|
|
|
|
|
|
Application Outlook (Revenue, USD million;
2018-2029)
|
Diagnostic Applications
|
Pre-transplantation Diagnostics
|
Infectious Disease Testing
|
|
|
Histocompatibility Testing
|
|
|
Blood Profiling
|
|
Post-transplantation Diagnostics
|
|
Research Applications
|
|
|
|
|
|
End User Outlook (Revenue, USD million;
2018-2029)
|
Hospitals & Transplant Centers
|
Independent Reference Laboratories
|
Research Laboratories & Academic Institutes
|
Product and Services Outlook:
On the basis of
Product and Services, the market is segmented into Instruments, Reagents &
Consumables, Software & Services.
Figure 1 - Transplant Diagnostics Market, By Product
and Services (Market Size And Forecast By Value - USD Million, 2021 & 2029)